In eukaryotes, entry into mitosis is regulated by the synergistic and opposing activities of a cascade of distinct protein kinases and phosphatases. This cascade converges on CDC2, a serine/threonine protein kinase required for the entry of cells into mitosis. Two neighboring amino acids within the N-terminus of CDC2 (threonine 14 and tyrosine 15) have been shown to be critical elements in regulating the kinase activity of CDC2. Phosphorylation of these residues quantatively inhibits the activity of the CDC2 kinase and thereby prevents cells from entering into mitosis. The goals of this grant are to characterize the kinases that either directly catalyze or indirectly regulate phosphorylation of these key residues. cDNAs encoding the human and Xenopus Thr14/Tyr 15 kinases will be isolated. Specific probes will be generated and each kinase will be characterized both in vitro and in vivo. In addition, upstream regulators of these enzymes will be identified. In fission yeast, the wee1, nim1/cdr1 and mik1 gene products will be studied. Finally, the optimal peptide motif for each kinase will be determined in order to identify potential substrates of the kinases (other that CDC2) and to develop specific peptide inhibitors for each kinase. These inhibitors will be used as in vivo probes of protein function and they may also serve as templates for the design of novel drugs targeted to diseases that arise as a result of aberrant cellular proliferation.

Agency
National Institute of Health (NIH)
Institute
National Institute of General Medical Sciences (NIGMS)
Type
Research Project (R01)
Project #
2R01GM047017-06
Application #
2184496
Study Section
Cellular Biology and Physiology Subcommittee 1 (CBY)
Project Start
1992-02-01
Project End
1999-01-31
Budget Start
1995-02-01
Budget End
1996-01-31
Support Year
6
Fiscal Year
1995
Total Cost
Indirect Cost
Name
Washington University
Department
Physiology
Type
Schools of Medicine
DUNS #
062761671
City
Saint Louis
State
MO
Country
United States
Zip Code
63130
Origanti, S; Cai, S-r; Munir, A Z et al. (2013) Synthetic lethality of Chk1 inhibition combined with p53 and/or p21 loss during a DNA damage response in normal and tumor cells. Oncogene 32:577-88
Huh, Jiwon; Piwnica-Worms, Helen (2013) CRL4(CDT2) targets CHK1 for PCNA-independent destruction. Mol Cell Biol 33:213-26
Honaker, Y; Piwnica-Worms, H (2010) Casein kinase 1 functions as both penultimate and ultimate kinase in regulating Cdc25A destruction. Oncogene 29:3324-34
Leung-Pineda, Van; Huh, Jiwon; Piwnica-Worms, Helen (2009) DDB1 targets Chk1 to the Cul4 E3 ligase complex in normal cycling cells and in cells experiencing replication stress. Cancer Res 69:2630-7
Kang, Tiebang; Wei, Yongkun; Honaker, Yuchi et al. (2008) GSK-3 beta targets Cdc25A for ubiquitin-mediated proteolysis, and GSK-3 beta inactivation correlates with Cdc25A overproduction in human cancers. Cancer Cell 13:36-47
Tarakanova, Vera L; Leung-Pineda, Van; Hwang, Seungmin et al. (2007) Gamma-herpesvirus kinase actively initiates a DNA damage response by inducing phosphorylation of H2AX to foster viral replication. Cell Host Microbe 1:275-86
Brooks, William S; Banerjee, Sami; Crawford, David F (2007) G2E3 is a nucleo-cytoplasmic shuttling protein with DNA damage responsive localization. Exp Cell Res 313:665-76
Rothblum-Oviatt, C J; Ryan, C E; Piwnica-Worms, H (2001) 14-3-3 binding regulates catalytic activity of human Wee1 kinase. Cell Growth Differ 12:581-9
Thorson, J A; Yu, L W; Hsu, A L et al. (1998) 14-3-3 proteins are required for maintenance of Raf-1 phosphorylation and kinase activity. Mol Cell Biol 18:5229-38
Peng, C Y; Graves, P R; Ogg, S et al. (1998) C-TAK1 protein kinase phosphorylates human Cdc25C on serine 216 and promotes 14-3-3 protein binding. Cell Growth Differ 9:197-208

Showing the most recent 10 out of 17 publications